There are 2789 resources available
1868P - Real-world safety of the 6-weekly pembrolizumab regimen in cancer patients treated in South East London
Presenter: Matthaios Kapiris
Session: ePoster Display
1869TiP - A phase II, multicenter, open-label study evaluating trastuzumab deruxtecan (T-DXd) for the treatment of select HER2-expressing solid tumors (DESTINY-PanTumor02)
Presenter: Funda Meric-Bernstam
Session: ePoster Display
1870TiP - Tazemetostat in combination with a PARP Inhibitor or checkpoint inhibitor in patients (Pts) with solid tumors
Presenter: Charles Rudin
Session: ePoster Display
1871TiP - PLATON – “Platform for Analyzing Targetable Tumor Mutations”: A pilot study
Presenter: Arndt Vogel
Session: ePoster Display
CN4 - Evaluation of the effectiveness of technology-based psychosocial education and counseling program for adolescent leukemia survivors: A randomised controlled trial
Presenter: Tuba Arpaci
Session: ePoster Display
CN5 - Wearable technology is it the future?
Presenter: Louise Cave
Session: ePoster Display
CN6 - The effect of the use of a mobile symptom management app during the chemotherapy of breast cancer
Presenter: Memnun Seven
Session: ePoster Display
CN7 - Prediction of onset timing of breakthrough pain using deep learning model
Presenter: Yoon Ho Choi
Session: ePoster Display
CN8 - The feasibility and utility of a mobile app in supporting Vietnamese children with cancer
Presenter: Nguyen Huu Duc
Session: ePoster Display
CN10 - Congruence between actual and preferred place of death by patients with oncological disease in palliative care and their caregivers in a primary care district of Cadiz
Presenter: Jose Manuel Martinez Nieto
Session: ePoster Display